Search for the regulatory factor of apoptosis in adult T-cell leukemia (ATL) cells

寻找成人T细胞白血病(ATL)细胞凋亡的调节因子

基本信息

  • 批准号:
    12670993
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

1. Anti-Fas monoclonal antibody (mAb) resistant adult T-cell leukemia (ATL) cell line, RS04RS04 RS04 cells did not show apoptosis after treatment with IgM anti-Fas mAb. We found that the lactacystin, which was a specific inhibitor of the proteosome, activated the caspase 8 and induced apoptosis in RS04 cells, indicating that the apoptotic pathway in the cytoplasm in RS04 cells was intact. By sequencing analysis of Fas gene, we found the heterozygous missense mutation with the transition of A to G at exon 2, resulting in substitution of arginine for histidine. The three dimensional molecular modeling of the mutated Fas protein indicated the definitive conformational alteration around the amino acids 52 to 58. It was suggested that the trimerization of Fas molecules was interfered with the mutated Fas, resulting in the impairment of signal transduction of apoptosis by dominant negative mechanism.2. Anti-Fas mAb resistantATL cell line, OMTIn OMT cells, we found the missense point mutation at nucleotide 1132 with the transition of T to C, resulting in the substitution of threonine for isoleucine. This mutation might cause the conformational alteration of death domain and fail to associate with the FADD molecule, which located at right downstream under the Fas molecule.3. ATL cells which barely express membrane FasBecause the Fas gene mutations were detected at the relatively high rate in Fas-resistant ATL cell lines, we investigated the primary ATL cells, which barely expressed membrane Fas and were resistant to IgM anti-Fas mAb. In four of seven cases of patients with ATL, we found Fas gene mutations, three point mutations and a 2 base pair deletion. It was indicated that the various mutations of Fas gene were one of the mechanisms of preventing the apoptosis in ATL cells.
1.抗Fas单克隆抗体(mAb)耐药的成人T细胞白血病(ATL)细胞株RS04 RS04经IgM抗Fas mAb处理后未出现凋亡。我们发现蛋白酶体的特异性抑制剂lactacystin可激活caspase 8并诱导RS04细胞凋亡,表明RS04细胞胞质内的凋亡途径是完整的。通过对Fas基因测序分析,发现该基因第2外显子存在A → G的杂合错义突变,导致组氨酸被精氨酸取代。突变的Fas蛋白的三维分子建模表明,围绕氨基酸52至58的明确的构象变化。提示突变的Fas干扰了Fas分子的三聚化,通过显性负性机制阻碍了凋亡信号转导.抗Fas单克隆抗体耐药ATL细胞株OMT中,我们发现OMT细胞中第1132位核苷酸发生错义突变,由T变为C,导致异亮氨酸被苏氨酸取代。该突变可能导致死亡结构域的构象改变,不能与位于Fas分子下游的FADD分子结合.由于Fas耐药的ATL细胞系中Fas基因突变率相对较高,我们研究了原代ATL细胞,这些细胞几乎不表达膜Fas,并对IgM抗Fas mAb具有耐药性。在7例ATL患者中,我们发现4例Fas基因突变,3个点突变和2个碱基对缺失。提示Fas基因的各种突变是抑制ATL细胞凋亡的机制之一。

项目成果

期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Isomoto H.: "Clinical and endoscopic features of adult T-cell leukemia/lymphoma with duodenal involvement report of three cases with a review of literature"J. Clin. Gastroenterol. 38. 241-246 (2001)
Isomoto H.:“成人T细胞白血病/淋巴瘤十二指肠受累的临床和内镜特征三例报告并文献复习”J.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Isomoto H.: "Jejunal perforation in a patient with adult T-cell leukemia"Leukemia and Lymphoma. 42. 1423-1427 (2001)
Isomoto H.:“成人 T 细胞白血病患者的空肠穿孔”白血病和淋巴瘤。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kamihira S.: "Clinical and oncological significance of aberrant Fas (APO-1/CD95) isoform expression in adult T-cell leukemia."Indian J.Clin.Biochem.. 15. 101-109 (2000)
Kamihira S.:“成人 T 细胞白血病中异常 Fas (APO-1/CD95) 亚型表达的临床和肿瘤学意义。”Indian J.Clin.Biochem.. 15. 101-109 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kamihira S.: "Real-time polymcrase chain reaction for quantification of HTLV-1 proviral load: application for analyzing aberrant integration of the proviral DNA in adult T-Cell leukemia"Int. J. Hematol.. 72. 79-84 (2000)
Kamihira S.:“用于定量 HTLV-1 前病毒载量的实时聚合酶链式反应:用于分析成人 T 细胞白血病中前病毒 DNA 的异常整合的应用”Int。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Isomoto H.: "Jejunal perforation in a patient with adult T-cell leukemia."Leukemia and Lymphoma. 42. 1423-1427 (2001)
Isomoto H.:“成人 T 细胞白血病患者的空肠穿孔。”白血病和淋巴瘤。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAEDA Takahiro其他文献

MAEDA Takahiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAEDA Takahiro', 18)}}的其他基金

An Empirical Study of the Determinants and Effects of Regulatory Enforcement Activities by Labor Standards Inspectors from a Resource-Based Theory Perspective
基于资源理论视角的劳动标准监察员监管执法活动的决定因素和效果实证研究
  • 批准号:
    20K13404
  • 财政年份:
    2020
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Cohort study regarding the association between chronic inflammation and HTLV-1 infection
关于慢性炎症与 HTLV-1 感染之间关联的队列研究
  • 批准号:
    17H03740
  • 财政年份:
    2017
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The longitudinal cohort study project related to atherosclerosis that connect the asymptomatic period and onset and
与动脉粥样硬化相关的纵向队列研究项目,将无症状期和发病期联系起来,
  • 批准号:
    25291107
  • 财政年份:
    2013
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Effect of 5 alpha reductase inhibitors for the steroid hormone and mens health
5 α 还原酶抑制剂对类固醇激素和男性健康的影响
  • 批准号:
    25861453
  • 财政年份:
    2013
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The physiological polymorphism of atherosclerosis investigated by genetic and environmental factors
遗传和环境因素研究动脉粥样硬化的生理多态性
  • 批准号:
    22370090
  • 财政年份:
    2010
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Control of kidney fibrosis in the mouse unilateral urethral obstruction model with the novel AP-1 inhibitor
新型 AP-1 抑制剂控制小鼠单侧尿道梗阻模型中的肾纤维化
  • 批准号:
    22791499
  • 财政年份:
    2010
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The elucidation of the physiological polymorphism related to arteriosclerosis by the approach method from genetic and acquired factor
从遗传和后天因素入手的方法阐明与动脉硬化相关的生理多态性
  • 批准号:
    19370104
  • 财政年份:
    2007
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Natural Killer (NK) Cell Immunotherapy Towards Adult T Cell Leukemia (ATL) via Exaltation of MICA/B Expression and Augments NK Cytotoxicity
通过提高 MICA/B 表达和增强 NK 细胞毒性来治疗成人 T 细胞白血病 (ATL) 的自然杀伤 (NK) 细胞免疫疗法
  • 批准号:
    22K16327
  • 财政年份:
    2022
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanism of adult T-cell leukemia (ATL) development based on gut microbiota analysis
基于肠道微生物群分析阐明成人 T 细胞白血病 (ATL) 发生的机制
  • 批准号:
    19K07693
  • 财政年份:
    2019
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Examination of the plasma miRNA profiles in adult T-cell leukemia (ATL)
成人 T 细胞白血病 (ATL) 血浆 miRNA 谱的检查
  • 批准号:
    18K10050
  • 财政年份:
    2018
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An investigation of the molecular mechanisms of action of lenalidomide in adult T-cell leukemia (ATL)
来那度胺治疗成人 T 细胞白血病 (ATL) 的分子机制研究
  • 批准号:
    17K14996
  • 财政年份:
    2017
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Analysis of the mechanism of hypoxia stress response in adult t-cell leukemia (ATL)
成人T细胞白血病(ATL)缺氧应激反应机制分析
  • 批准号:
    16K07120
  • 财政年份:
    2016
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Single cell analysis of dynamic change of epigenetic abnormalities in adult T cell leukemia/lymphoma (ATL)
成人T细胞白血病/淋巴瘤(ATL)表观遗传异常动态变化的单细胞分析
  • 批准号:
    16K08667
  • 财政年份:
    2016
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Quantitative membrane-proteome analysis to discover novel therapeutic targets for adult T-cell leukemia (ATL)
定量膜蛋白质组分析发现成人 T 细胞白血病 (ATL) 的新治疗靶点
  • 批准号:
    25830126
  • 财政年份:
    2013
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Epigenetic abnormalities during onset and progression of adult T-cell leukemia/lymphoma (ATL)
成人 T 细胞白血病/淋巴瘤 (ATL) 发病和进展过程中的表观遗传异常
  • 批准号:
    25460437
  • 财政年份:
    2013
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Quantitative proteome profiling to identify biomarkers and therapeutic targets for adult T-cell leukemia (ATL).
定量蛋白质组分析可鉴定成人 T 细胞白血病 (ATL) 的生物标志物和治疗靶点。
  • 批准号:
    23701090
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Research for Immunotherapy of Adult T cell Leukemia(ATL)
成人T细胞白血病(ATL)免疫治疗研究
  • 批准号:
    21590521
  • 财政年份:
    2009
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了